Skip to content
value.today

Vivorte Inc.

🇺🇸 Louisville, Kentucky, USABiotechnologyFounded 2010
Total raised
$4 M
1 round on record
Latest round
$4 M
Dec 2010
First round on record
Dec 2010
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Vivorte Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2010$4 MNo. 1$2 to $10 million

Vivorte Inc.: Raise no. 1, Dec 2010

Investors in this round

74 investors had bought by the notice of Jul 25, 2013: 74 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $5 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michael Voor · Executive Officer, Director
  • Ruth Voor · Executive Officer, Director
  • Robert Saunders · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On a merger: “The initial round in this offering was made in connection with an exchange by certain investors of their interests in Vivorte, LLC for equity in the Issuer.The additional investment amount reflected in this amendment does not entail an equity exchange.”

Signed by Ruth Voor, CEO/Secretary/Treasurer. Source: SEC Form D and 1 amendment, newest notice filed Jul 25, 2013. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Vivorte Inc. had no revenue when it filed its newest notice of a funding round (Jul 2013).

    SEC Form D (revenue range) · Jul 2013

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jul 2013

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Vivorte Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 74 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Vivorte Inc.
NameRoleNamed in
Michael VoorExecutive officerJul 2013
Ruth VoorExecutive officerJul 2013
Michael VoorDirectorJul 2013
Robert SaundersDirectorJul 2013
Ruth VoorDirectorJul 2013